Malignancy in ankylosing spondylitis: a cross-sectional analysis of a large population database

Abstract Background Increased cancer-risk has been reported with rheumatoid arthritis and systemic lupus erythematosus, but the risk is poorly studied in ankylosing spondylitis (AS). Conflicting data in AS have been reported in Asia and Europe, with lack of US population-based studies. Our objective...

Full description

Bibliographic Details
Main Authors: Mohamad Bittar, Sali Merjanah, Reem Alkilany, Marina Magrey
Format: Article
Language:English
Published: BMC 2022-06-01
Series:BMC Rheumatology
Subjects:
Online Access:https://doi.org/10.1186/s41927-022-00275-x
_version_ 1817976517673615360
author Mohamad Bittar
Sali Merjanah
Reem Alkilany
Marina Magrey
author_facet Mohamad Bittar
Sali Merjanah
Reem Alkilany
Marina Magrey
author_sort Mohamad Bittar
collection DOAJ
description Abstract Background Increased cancer-risk has been reported with rheumatoid arthritis and systemic lupus erythematosus, but the risk is poorly studied in ankylosing spondylitis (AS). Conflicting data in AS have been reported in Asia and Europe, with lack of US population-based studies. Our objective is to study the prevalence of cancer in patients with AS in the US. Methods Using the Explorys database, we performed a cross-sectional study. Data from AS patients and controls were stratified by 2 rheumatology visits, age groups, clinical characteristics, and frequency of cancers. The data were analyzed using a series of chi-square tests of independence as well as logistic regression to test for association between AS and cancer. Results 1410 AS patients (12.88%) had cancer. Female AS patients had a lower prevalence of cancer compared to controls (OR 0.840, 95% CI [0.769, 0.916]), while male AS patients had no statistically significant difference (OR 1.011, 95% CI [0.929, 1.099]). Among patients with AS, Skin cancers (squamous cell, malignant melanoma, and basal cell) and head and neck cancers were significantly increased. Conclusion Our study demonstrated that the prevalence of “any-type-cancer” was not increased in AS patients compared to controls with no rheumatic disease. Skin, head, and neck cancers were more frequently seen in AS patients.
first_indexed 2024-04-13T22:04:38Z
format Article
id doaj.art-eae3dd62d8834b89a981dd4aa2e698c2
institution Directory Open Access Journal
issn 2520-1026
language English
last_indexed 2024-04-13T22:04:38Z
publishDate 2022-06-01
publisher BMC
record_format Article
series BMC Rheumatology
spelling doaj.art-eae3dd62d8834b89a981dd4aa2e698c22022-12-22T02:27:59ZengBMCBMC Rheumatology2520-10262022-06-01611610.1186/s41927-022-00275-xMalignancy in ankylosing spondylitis: a cross-sectional analysis of a large population databaseMohamad Bittar0Sali Merjanah1Reem Alkilany2Marina Magrey3Division of Connective Tissue Disease (Rheumatology), The University of Tennessee Health Science CenterDivision of Rheumatology, Boston UniversityDepartment of Medicine, The MetroHealth System Campus of Case Western Reserve UniversityDivision of Rheumatology, University Hospitals/Case Western Reserve UniversityAbstract Background Increased cancer-risk has been reported with rheumatoid arthritis and systemic lupus erythematosus, but the risk is poorly studied in ankylosing spondylitis (AS). Conflicting data in AS have been reported in Asia and Europe, with lack of US population-based studies. Our objective is to study the prevalence of cancer in patients with AS in the US. Methods Using the Explorys database, we performed a cross-sectional study. Data from AS patients and controls were stratified by 2 rheumatology visits, age groups, clinical characteristics, and frequency of cancers. The data were analyzed using a series of chi-square tests of independence as well as logistic regression to test for association between AS and cancer. Results 1410 AS patients (12.88%) had cancer. Female AS patients had a lower prevalence of cancer compared to controls (OR 0.840, 95% CI [0.769, 0.916]), while male AS patients had no statistically significant difference (OR 1.011, 95% CI [0.929, 1.099]). Among patients with AS, Skin cancers (squamous cell, malignant melanoma, and basal cell) and head and neck cancers were significantly increased. Conclusion Our study demonstrated that the prevalence of “any-type-cancer” was not increased in AS patients compared to controls with no rheumatic disease. Skin, head, and neck cancers were more frequently seen in AS patients.https://doi.org/10.1186/s41927-022-00275-xAnkylosing spondylitisAxial spondyloarthritisMalignancyCancerEpidemiology
spellingShingle Mohamad Bittar
Sali Merjanah
Reem Alkilany
Marina Magrey
Malignancy in ankylosing spondylitis: a cross-sectional analysis of a large population database
BMC Rheumatology
Ankylosing spondylitis
Axial spondyloarthritis
Malignancy
Cancer
Epidemiology
title Malignancy in ankylosing spondylitis: a cross-sectional analysis of a large population database
title_full Malignancy in ankylosing spondylitis: a cross-sectional analysis of a large population database
title_fullStr Malignancy in ankylosing spondylitis: a cross-sectional analysis of a large population database
title_full_unstemmed Malignancy in ankylosing spondylitis: a cross-sectional analysis of a large population database
title_short Malignancy in ankylosing spondylitis: a cross-sectional analysis of a large population database
title_sort malignancy in ankylosing spondylitis a cross sectional analysis of a large population database
topic Ankylosing spondylitis
Axial spondyloarthritis
Malignancy
Cancer
Epidemiology
url https://doi.org/10.1186/s41927-022-00275-x
work_keys_str_mv AT mohamadbittar malignancyinankylosingspondylitisacrosssectionalanalysisofalargepopulationdatabase
AT salimerjanah malignancyinankylosingspondylitisacrosssectionalanalysisofalargepopulationdatabase
AT reemalkilany malignancyinankylosingspondylitisacrosssectionalanalysisofalargepopulationdatabase
AT marinamagrey malignancyinankylosingspondylitisacrosssectionalanalysisofalargepopulationdatabase